Skip to main content

Posted by Newsbytes

Medicare finalized its decision to restrict its coverage of Aduhelm, Biogen’s new Alzheimer’s disease drug, on April 8, 2022.The decision means only patients who have enrolled in clinical trials , will receive Medicare coverage for Aduhelm which goes by the generic drug name of Aducanumab. Read more

Giving Kids in Need the Chance to Read
  Non-profit organization - Seattle, WA

Powered by Volunteers | 360-794-7959

Click the Image to learn more about us

Read more from Pepe's Painting LLC
Read more from Kudos 365

Hunger impacts all of us | 360-435-1631

Snohomish, Skagit and Island County